United States Biotechnology & Medical Research

Otonomy Inc (OTIC)

Track

Track

Ticker: OTIC Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
CAPPS VICKIE L Non-Executive Director
Transaction date
Sale
Price
365.06
Quantity 25,548 -44.2%
Value US$1,977,461
Foster Alan Charles Chief Scientific Officer Officer
Transaction date
Sale
Price
284.28
Quantity 67,110 +19.5%
Value US$1,529,154
Cayer Paul E Ch. Financial & Business Offcr Officer
Transaction date
Sale
Price
267.89
Quantity 51,193 -39.1%
Value US$3,696,211
Savel Robert Michael II Chief Technical Officer Officer
Transaction date
Sale
Price
2.41
Quantity 3,325 -2.2%
Value US$8,023
Weber David Allen President & CEO Executive Director
Transaction date
Sale
Price
2.41
Quantity 11,243 -2.9%
Value US$27,129
Foster Alan Charles Chief Scientific Officer Officer
Transaction date
Sale
Price
2.39
Quantity 1,827 -1.0%
Value US$4,363
Cayer Paul E Ch. Financial & Business Offcr Officer
Transaction date
Sale
Price
2.39
Quantity 4,015 -1.7%
Value US$9,588
Savel Robert Michael II Chief Technical Officer Officer
Transaction date
Sale
Price
2.39
Quantity 2,374 -1.6%
Value US$5,669
Weber David Allen President & CEO Executive Director
Transaction date
Sale
Price
2.39
Quantity 8,026 -2.0%
Value US$19,166
4.0
Lichter Jay Non-Executive Director
Transaction date
Sale
Price
2.70
Quantity 113,935 -100.0%
Value US$307,397
4.0
Lichter Jay Non-Executive Director
Transaction date
Sale
Price
2.70
Quantity 207,245 -100.0%
Value US$559,147
4.0
Lichter Jay Non-Executive Director
Transaction date
Sale
Price
2.90
Quantity 138,199 -54.8%
Value US$400,639
4.0
Lichter Jay Non-Executive Director
Transaction date
Sale
Price
2.90
Quantity 251,375 -54.8%
Value US$728,736
4.0
Lichter Jay Non-Executive Director
Transaction date
Sale
Price
2.86
Quantity 61,619 -19.6%
Value US$175,984
4.0
Lichter Jay Non-Executive Director
Transaction date
Sale
Price
2.86
Quantity 112,081 -19.6%
Value US$320,103
4.0
Lichter Jay Non-Executive Director
Transaction date
Sale
Price
2.83
Quantity 117,262 -27.2%
Value US$331,851
4.0
Lichter Jay Non-Executive Director
Transaction date
Sale
Price
2.83
Quantity 213,292 -27.2%
Value US$603,616
4.0
Lichter Jay Non-Executive Director
Transaction date
Sale
Price
2.95
Quantity 110,361 -20.4%
Value US$326,006
4.0
Lichter Jay Non-Executive Director
Transaction date
Sale
Price
2.95
Quantity 200,739 -20.4%
Value US$592,983
4.0
Lichter Jay Non-Executive Director
Transaction date
Sale
Price
2.98
Quantity 178,484 -24.8%
Value US$532,239
4.0
Lichter Jay Non-Executive Director
Transaction date
Sale
Price
2.98
Quantity 324,651 -24.8%
Value US$968,109
4.0
Lichter Jay Non-Executive Director
Transaction date
Sale
Price
2.89
Quantity 95,113 -11.7%
Value US$274,686
4.0
Lichter Jay Non-Executive Director
Transaction date
Sale
Price
2.89
Quantity 173,005 -11.7%
Value US$499,638
LOUMEAU ERIC J GC & Chief Compliance Officer
Transaction date
Planned sale
Price
18.75
Quantity 1,206 -100.0%
Value US$22,612
LOUMEAU ERIC J GC & Chief Compliance Officer
Transaction date
Planned sale
Price
18.50
Quantity 2,316 -65.8%
Value US$42,846
LeBel Carl Chief Scientific Officer Officer
Transaction date
Planned sale
Price
18.07
Quantity 1,456 -13.3%
Value US$26,303
LeBel Carl Chief Scientific Officer Officer
Transaction date
Planned sale
Price
18.07
Quantity 9,169 -49.2%
Value US$165,703
LeBel Carl Chief Scientific Officer Officer
Transaction date
Planned sale
Price
17.95
Quantity 5,304 -35.9%
Value US$95,207
LeBel Carl Chief Scientific Officer Officer
Transaction date
Planned sale
Price
17.95
Quantity 3,813 -20.5%
Value US$68,443
LeBel Carl Chief Scientific Officer Officer
Transaction date
Planned sale
Price
17.95
Quantity 12,133 -39.5%
Value US$217,787
LeBel Carl Chief Scientific Officer Officer
Transaction date
Planned sale
Price
28.38
Quantity 8,061 -47.5%
Value US$228,753
LeBel Carl Chief Scientific Officer Officer
Transaction date
Planned sale
Price
27.83
Quantity 13,189 -43.7%
Value US$367,074
Cayer Paul E Ch. Financial & Business Offcr Officer
Transaction date
Planned sale
Price
30.19
Quantity 300 -3.0%
Value US$9,056
Cayer Paul E Ch. Financial & Business Offcr Officer
Transaction date
Planned sale
Price
29.65
Quantity 2,700 -21.4%
Value US$80,045
Weber David Allen President & CEO Executive Director
Transaction date
Planned sale
Price
27.25
Quantity 5,208 -22.8%
Value US$141,917
Savel Robert Michael II Chief Technical Officer Officer
Transaction date
Sale
Price
27.70
Quantity 100 -7.4%
Value US$2,770
Savel Robert Michael II Chief Technical Officer Officer
Transaction date
Sale
Price
27.26
Quantity 1,289 -48.7%
Value US$35,136
Savel Robert Michael II Chief Technical Officer Officer
Transaction date
Sale
Price
26.15
Quantity 1,289 -32.8%
Value US$33,706
Savel Robert Michael II Chief Technical Officer Officer
Transaction date
Planned sale
Price
25.14
Quantity 2,322 -37.1%
Value US$58,363
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
29.22
Quantity 590 -0.0%
Value US$17,240
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
28.64
Quantity 2,716 -0.1%
Value US$77,786
Khuong Chau Quang Non-Executive Director
Transaction date
Sale
Price
29.22
Quantity 590 -0.0%
Value US$17,240
Khuong Chau Quang Non-Executive Director
Transaction date
Sale
Price
28.64
Quantity 2,716 -0.1%
Value US$77,786
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
28.97
Quantity 29,000 -1.5%
Value US$840,130
Khuong Chau Quang Non-Executive Director
Transaction date
Sale
Price
28.97
Quantity 29,000 -1.5%
Value US$840,130
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
28.91
Quantity 34,800 -1.8%
Value US$1,006,068
Khuong Chau Quang Non-Executive Director
Transaction date
Sale
Price
28.91
Quantity 34,800 -1.8%
Value US$1,006,068
Khuong Chau Quang Non-Executive Director
Transaction date
Sale
Price
28.75
Quantity 36,100 -1.8%
Value US$1,037,875
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
28.75
Quantity 36,100 -1.8%
Value US$1,037,875
Khuong Chau Quang Non-Executive Director
Transaction date
Sale
Price
28.45
Quantity 80,800 -4.0%
Value US$2,298,760
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
28.45
Quantity 80,800 -4.0%
Value US$2,298,760
Khuong Chau Quang Non-Executive Director
Transaction date
Sale
Price
28.59
Quantity 83,900 -4.0%
Value US$2,398,701
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
28.59
Quantity 83,900 -4.0%
Value US$2,398,701
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
28.60
Quantity 127,300 -5.7%
Value US$3,640,780
Khuong Chau Quang Non-Executive Director
Transaction date
Sale
Price
28.60
Quantity 127,300 -5.7%
Value US$3,640,780
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
29.09
Quantity 200 -0.0%
Value US$5,818
Khuong Chau Quang Non-Executive Director
Transaction date
Sale
Price
29.09
Quantity 200 -0.0%
Value US$5,818
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
28.80
Quantity 10,898 -0.5%
Value US$313,862
Khuong Chau Quang Non-Executive Director
Transaction date
Sale
Price
28.80
Quantity 10,898 -0.5%
Value US$313,862
Cayer Paul E Ch. Financial & Business Offcr Officer
Transaction date
Planned sale
Price
28.69
Quantity 3,000 -23.8%
Value US$86,057
Weber David Allen President & CEO Executive Director
Transaction date
Sale
Price
29.25
Quantity 100 -0.6%
Value US$2,925
Weber David Allen President & CEO Executive Director
Transaction date
Planned sale
Price
28.56
Quantity 5,108 -22.4%
Value US$145,887
Weber David Allen President & CEO Executive Director
Transaction date
Planned sale
Price
30.95
Quantity 10,416 -95.1%
Value US$322,375
Cayer Paul E CFO/Ch. Business Offcr & Sec. Officer
Transaction date
Planned sale
Price
24.95
Quantity 3,000 -23.8%
Value US$74,850
Weber David Allen President & CEO Executive Director
Transaction date
Planned sale
Price
24.95
Quantity 5,208 -90.6%
Value US$129,940
LeBel Carl Chief Scientific Officer Officer
Transaction date
Planned sale
Price
24.36
Quantity 21,250 -70.4%
Value US$517,576
Cayer Paul E CFO/Ch. Business Offcr & Sec. Officer
Transaction date
Planned sale
Price
24.95
Quantity 3,000 -23.8%
Value US$74,850
Weber David Allen President & CEO Executive Director
Transaction date
Planned sale
Price
24.95
Quantity 5,216 -90.6%
Value US$130,139
Savel Robert Michael II Chief Technical Officer Officer
Transaction date
Planned sale
Price
23.98
Quantity 5,000 -79.9%
Value US$119,896
Savel Robert Michael II Chief Technical Officer Officer
Transaction date
Planned sale
Price
23.73
Quantity 25,000 -95.2%
Value US$593,285
CAPPS VICKIE L Non-Executive Director
Transaction date
Purchase
Price
24.35
Quantity 1,600 +inf%
Value US$38,960
CAPPS VICKIE L Non-Executive Director
Transaction date
Purchase
Price
24.36
Quantity 3,400 +inf%
Value US$82,808
Novo A/S SEE REMARKS Large shareholder
Transaction date
Purchase
Price
15.50
Quantity 15,690 +0.7%
Value US$243,135
Novo A/S SEE REMARKS Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 171,875 +8.6%
Value US$2,750,000
Avalon Ventures VIII LP Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 109,375 +15.5%
Value US$1,750,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-29 2022-11-28 S Sale
2.2
CAPPS VICKIE L
Non-Executive Director
25,548 -44.2%
365.06
US$1,977,461 		25,548 -44.2% 365.06 US$1,977,461
2022-03-29 2022-03-28 S Sale
Foster Alan Charles

Chief Scientific Officer

Officer
67,110 +19.5%
284.28
US$1,529,154 		67,110 +19.5% 284.28 US$1,529,154
2022-03-29 2022-03-28 S Sale
Cayer Paul E

Ch. Financial & Business Offcr

Officer
51,193 -39.1%
267.89
US$3,696,211 		51,193 -39.1% 267.89 US$3,696,211
2022-03-29 2022-03-28 S Sale
Savel Robert Michael II

Chief Technical Officer

Officer
3,325 -2.2%
2.41
US$8,023 		3,325 -2.2% 2.41 US$8,023
2022-03-29 2022-03-28 S Sale
Weber David Allen

President & CEO

Executive Director
11,243 -2.9%
2.41
US$27,129 		11,243 -2.9% 2.41 US$27,129
2022-03-29 2022-03-25 S Sale
Foster Alan Charles

Chief Scientific Officer

Officer
1,827 -1.0%
2.39
US$4,363 		1,827 -1.0% 2.39 US$4,363
2022-03-29 2022-03-25 S Sale
Cayer Paul E

Ch. Financial & Business Offcr

Officer
4,015 -1.7%
2.39
US$9,588 		4,015 -1.7% 2.39 US$9,588
2022-03-29 2022-03-25 S Sale
Savel Robert Michael II

Chief Technical Officer

Officer
2,374 -1.6%
2.39
US$5,669 		2,374 -1.6% 2.39 US$5,669
2022-03-29 2022-03-25 S Sale
Weber David Allen

President & CEO

Executive Director
8,026 -2.0%
2.39
US$19,166 		8,026 -2.0% 2.39 US$19,166
2021-03-03 2021-03-03 S Sale
4.0
Lichter Jay
Non-Executive Director
113,935 -100.0%
2.70
US$307,397 		113,935 -100.0% 2.70 US$307,397
2021-03-03 2021-03-03 S Sale
4.0
Lichter Jay
Non-Executive Director
207,245 -100.0%
2.70
US$559,147 		207,245 -100.0% 2.70 US$559,147
2021-03-02 2021-03-02 S Sale
4.0
Lichter Jay
Non-Executive Director
138,199 -54.8%
2.90
US$400,639 		138,199 -54.8% 2.90 US$400,639
2021-03-02 2021-03-02 S Sale
4.0
Lichter Jay
Non-Executive Director
251,375 -54.8%
2.90
US$728,736 		251,375 -54.8% 2.90 US$728,736
2021-03-02 2021-03-01 S Sale
4.0
Lichter Jay
Non-Executive Director
61,619 -19.6%
2.86
US$175,984 		61,619 -19.6% 2.86 US$175,984
2021-03-02 2021-03-01 S Sale
4.0
Lichter Jay
Non-Executive Director
112,081 -19.6%
2.86
US$320,103 		112,081 -19.6% 2.86 US$320,103
2021-03-02 2021-02-26 S Sale
4.0
Lichter Jay
Non-Executive Director
117,262 -27.2%
2.83
US$331,851 		117,262 -27.2% 2.83 US$331,851
2021-03-02 2021-02-26 S Sale
4.0
Lichter Jay
Non-Executive Director
213,292 -27.2%
2.83
US$603,616 		213,292 -27.2% 2.83 US$603,616
2021-02-25 2021-02-25 S Sale
4.0
Lichter Jay
Non-Executive Director
110,361 -20.4%
2.95
US$326,006 		110,361 -20.4% 2.95 US$326,006
2021-02-25 2021-02-25 S Sale
4.0
Lichter Jay
Non-Executive Director
200,739 -20.4%
2.95
US$592,983 		200,739 -20.4% 2.95 US$592,983
2021-02-25 2021-02-24 S Sale
4.0
Lichter Jay
Non-Executive Director
178,484 -24.8%
2.98
US$532,239 		178,484 -24.8% 2.98 US$532,239
2021-02-25 2021-02-24 S Sale
4.0
Lichter Jay
Non-Executive Director
324,651 -24.8%
2.98
US$968,109 		324,651 -24.8% 2.98 US$968,109
2021-02-25 2021-02-23 S Sale
4.0
Lichter Jay
Non-Executive Director
95,113 -11.7%
2.89
US$274,686 		95,113 -11.7% 2.89 US$274,686
2021-02-25 2021-02-23 S Sale
4.0
Lichter Jay
Non-Executive Director
173,005 -11.7%
2.89
US$499,638 		173,005 -11.7% 2.89 US$499,638
2017-06-27 2017-06-26 PlS Planned sale LOUMEAU ERIC J

GC & Chief Compliance Officer
1,206 -100.0%
18.75
US$22,612 		1,206 -100.0% 18.75 US$22,612
2017-06-27 2017-06-23 PlS Planned sale LOUMEAU ERIC J

GC & Chief Compliance Officer
2,316 -65.8%
18.50
US$42,846 		2,316 -65.8% 18.50 US$42,846
2016-11-22 2016-11-21 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
1,456 -13.3%
18.07
US$26,303 		1,456 -13.3% 18.07 US$26,303
2016-11-22 2016-11-18 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
9,169 -49.2%
18.07
US$165,703 		9,169 -49.2% 18.07 US$165,703
2016-09-08 2016-09-06 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
5,304 -35.9%
17.95
US$95,207 		5,304 -35.9% 17.95 US$95,207
2016-09-08 2016-09-06 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
3,813 -20.5%
17.95
US$68,443 		3,813 -20.5% 17.95 US$68,443
2016-09-08 2016-09-06 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
12,133 -39.5%
17.95
US$217,787 		12,133 -39.5% 17.95 US$217,787
2015-12-22 2015-12-21 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
8,061 -47.5%
28.38
US$228,753 		8,061 -47.5% 28.38 US$228,753
2015-12-22 2015-12-21 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
13,189 -43.7%
27.83
US$367,074 		13,189 -43.7% 27.83 US$367,074
2015-12-18 2015-12-17 PlS Planned sale Cayer Paul E

Ch. Financial & Business Offcr

Officer
300 -3.0%
30.19
US$9,056 		300 -3.0% 30.19 US$9,056
2015-12-18 2015-12-17 PlS Planned sale Cayer Paul E

Ch. Financial & Business Offcr

Officer
2,700 -21.4%
29.65
US$80,045 		2,700 -21.4% 29.65 US$80,045
2015-12-16 2015-12-15 PlS Planned sale Weber David Allen

President & CEO

Executive Director
5,208 -22.8%
27.25
US$141,917 		5,208 -22.8% 27.25 US$141,917
2015-12-16 2015-12-14 S Sale Savel Robert Michael II

Chief Technical Officer

Officer
100 -7.4%
27.70
US$2,770 		100 -7.4% 27.70 US$2,770
2015-12-16 2015-12-14 S Sale Savel Robert Michael II

Chief Technical Officer

Officer
1,289 -48.7%
27.26
US$35,136 		1,289 -48.7% 27.26 US$35,136
2015-12-16 2015-12-14 S Sale Savel Robert Michael II

Chief Technical Officer

Officer
1,289 -32.8%
26.15
US$33,706 		1,289 -32.8% 26.15 US$33,706
2015-12-16 2015-12-14 PlS Planned sale Savel Robert Michael II

Chief Technical Officer

Officer
2,322 -37.1%
25.14
US$58,363 		2,322 -37.1% 25.14 US$58,363
2015-11-30 2015-11-30 S Sale ORBIMED ADVISORS LLC Non-Executive Director
590 -0.0%
29.22
US$17,240 		590 -0.0% 29.22 US$17,240
2015-11-30 2015-11-30 S Sale ORBIMED ADVISORS LLC Non-Executive Director
2,716 -0.1%
28.64
US$77,786 		2,716 -0.1% 28.64 US$77,786
2015-11-30 2015-11-30 S Sale Khuong Chau Quang Non-Executive Director
590 -0.0%
29.22
US$17,240 		590 -0.0% 29.22 US$17,240
2015-11-30 2015-11-30 S Sale Khuong Chau Quang Non-Executive Director
2,716 -0.1%
28.64
US$77,786 		2,716 -0.1% 28.64 US$77,786
2015-11-30 2015-11-27 S Sale ORBIMED ADVISORS LLC Non-Executive Director
29,000 -1.5%
28.97
US$840,130 		29,000 -1.5% 28.97 US$840,130
2015-11-30 2015-11-27 S Sale Khuong Chau Quang Non-Executive Director
29,000 -1.5%
28.97
US$840,130 		29,000 -1.5% 28.97 US$840,130
2015-11-30 2015-11-25 S Sale ORBIMED ADVISORS LLC Non-Executive Director
34,800 -1.8%
28.91
US$1,006,068 		34,800 -1.8% 28.91 US$1,006,068
2015-11-30 2015-11-25 S Sale Khuong Chau Quang Non-Executive Director
34,800 -1.8%
28.91
US$1,006,068 		34,800 -1.8% 28.91 US$1,006,068
2015-11-24 2015-11-24 S Sale Khuong Chau Quang Non-Executive Director
36,100 -1.8%
28.75
US$1,037,875 		36,100 -1.8% 28.75 US$1,037,875
2015-11-24 2015-11-24 S Sale ORBIMED ADVISORS LLC Non-Executive Director
36,100 -1.8%
28.75
US$1,037,875 		36,100 -1.8% 28.75 US$1,037,875
2015-11-24 2015-11-23 S Sale Khuong Chau Quang Non-Executive Director
80,800 -4.0%
28.45
US$2,298,760 		80,800 -4.0% 28.45 US$2,298,760
2015-11-24 2015-11-23 S Sale ORBIMED ADVISORS LLC Non-Executive Director
80,800 -4.0%
28.45
US$2,298,760 		80,800 -4.0% 28.45 US$2,298,760
2015-11-24 2015-11-20 S Sale Khuong Chau Quang Non-Executive Director
83,900 -4.0%
28.59
US$2,398,701 		83,900 -4.0% 28.59 US$2,398,701
2015-11-24 2015-11-20 S Sale ORBIMED ADVISORS LLC Non-Executive Director
83,900 -4.0%
28.59
US$2,398,701 		83,900 -4.0% 28.59 US$2,398,701
2015-11-19 2015-11-19 S Sale ORBIMED ADVISORS LLC Non-Executive Director
127,300 -5.7%
28.60
US$3,640,780 		127,300 -5.7% 28.60 US$3,640,780
2015-11-19 2015-11-19 S Sale Khuong Chau Quang Non-Executive Director
127,300 -5.7%
28.60
US$3,640,780 		127,300 -5.7% 28.60 US$3,640,780
2015-11-19 2015-11-17 S Sale ORBIMED ADVISORS LLC Non-Executive Director
200 -0.0%
29.09
US$5,818 		200 -0.0% 29.09 US$5,818
2015-11-19 2015-11-17 S Sale Khuong Chau Quang Non-Executive Director
200 -0.0%
29.09
US$5,818 		200 -0.0% 29.09 US$5,818
2015-11-19 2015-11-17 S Sale ORBIMED ADVISORS LLC Non-Executive Director
10,898 -0.5%
28.80
US$313,862 		10,898 -0.5% 28.80 US$313,862
2015-11-19 2015-11-17 S Sale Khuong Chau Quang Non-Executive Director
10,898 -0.5%
28.80
US$313,862 		10,898 -0.5% 28.80 US$313,862
2015-11-17 2015-11-17 PlS Planned sale Cayer Paul E

Ch. Financial & Business Offcr

Officer
3,000 -23.8%
28.69
US$86,057 		3,000 -23.8% 28.69 US$86,057
2015-11-17 2015-11-16 S Sale Weber David Allen

President & CEO

Executive Director
100 -0.6%
29.25
US$2,925 		100 -0.6% 29.25 US$2,925
2015-11-17 2015-11-16 PlS Planned sale Weber David Allen

President & CEO

Executive Director
5,108 -22.4%
28.56
US$145,887 		5,108 -22.4% 28.56 US$145,887
2015-11-13 2015-11-13 PlS Planned sale Weber David Allen

President & CEO

Executive Director
10,416 -95.1%
30.95
US$322,375 		10,416 -95.1% 30.95 US$322,375
2015-11-12 2015-11-11 PlS Planned sale Cayer Paul E

CFO/Ch. Business Offcr & Sec.

Officer
3,000 -23.8%
24.95
US$74,850 		3,000 -23.8% 24.95 US$74,850
2015-11-12 2015-11-11 PlS Planned sale Weber David Allen

President & CEO

Executive Director
5,208 -90.6%
24.95
US$129,940 		5,208 -90.6% 24.95 US$129,940
2015-09-22 2015-09-21 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
21,250 -70.4%
24.36
US$517,576 		21,250 -70.4% 24.36 US$517,576
2015-09-18 2015-09-17 PlS Planned sale Cayer Paul E

CFO/Ch. Business Offcr & Sec.

Officer
3,000 -23.8%
24.95
US$74,850 		3,000 -23.8% 24.95 US$74,850
2015-09-16 2015-09-15 PlS Planned sale Weber David Allen

President & CEO

Executive Director
5,216 -90.6%
24.95
US$130,139 		5,216 -90.6% 24.95 US$130,139
2015-09-15 2015-09-14 PlS Planned sale Savel Robert Michael II

Chief Technical Officer

Officer
5,000 -79.9%
23.98
US$119,896 		5,000 -79.9% 23.98 US$119,896
2015-06-17 2015-06-15 PlS Planned sale Savel Robert Michael II

Chief Technical Officer

Officer
25,000 -95.2%
23.73
US$593,285 		25,000 -95.2% 23.73 US$593,285
2015-05-27 2015-05-22 B Purchase CAPPS VICKIE L Non-Executive Director
1,600 +inf%
24.35
US$38,960 		1,600 +inf% 24.35 US$38,960
2015-05-27 2015-05-22 B Purchase CAPPS VICKIE L Non-Executive Director
3,400 +inf%
24.36
US$82,808 		3,400 +inf% 24.36 US$82,808
2014-08-21 2014-08-19 B Purchase Novo A/S

SEE REMARKS

Large shareholder
15,690 +0.7%
15.50
US$243,135 		15,690 +0.7% 15.50 US$243,135
2014-08-19 2014-08-18 B Purchase Novo A/S

SEE REMARKS

Large shareholder
171,875 +8.6%
16.00
US$2,750,000 		171,875 +8.6% 16.00 US$2,750,000
2014-08-19 2014-08-18 B Purchase Avalon Ventures VIII LP Large shareholder
109,375 +15.5%
16.00
US$1,750,000 		109,375 +15.5% 16.00 US$1,750,000
Explore more

More insider trading research around Otonomy Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America